Steve Roon is a sales & marketing executive with 30+ years in the medical device/diagnostic industry. While at major multi-national and private start-up companies, he has launched numerous new products, has created distribution networks in over 40 countries plus established a clinical diagnostic Joint Venture in China. Recently, he was part of the senior executive team that took Vivione Biosciences public on the Canadian TSX Venture Exchange.

Dr. Moroz is a physician with 10+ years of cancer research experience at the Memorial Sloan Kettering Cancer Center manipulating the tumor micro-environment to enhance CAR-T cell therapy. She has expertise in various molecular, biochemical and cell biology techniques including cell-based assays utilizing molecular and metabolic imaging modalities. Her Certification in Clinical and Translation Investigation is from Weill Cornell Medical College.

Chris Apfel, MD, PhD, MBA, is co-chair of the Life Science Committee of the Keiretsu Forum, Drug and Device Screening Committees of Life Science Angels, and an active angel investor. As a result of close family members having been affected by cancer and recognizing the diagnostic limitations inherent to genomic sequencing today, Chris started SageMedic. He left his clinical practice at UCSF, got his MBA from Wharton, and started SageMedic.